Glycemic Targets for Pregnant Women With GDM and T2DM

Glycemic Targets for Pregnant Women With GDM and T2DM
  • Total prenatal care visits [ Time Frame: 41 weeks gestation ]

    Total number of prenatal care visits during pregnancy

  • Prenatal care visits after enrollment [ Time Frame: 41 weeks gestation ]

    Number of prenatal care visits after enrollment

  • Prenatal care visits: log/glucometer [ Time Frame: 41 weeks gestation ]

    Number of prenatal care visits with log/glucometer available for RN or MD to review

  • Prenatal care visits: targets met [ Time Frame: 41 weeks gestation ]

    Number of prenatal care visits in which patient met blood sugar targets

  • Prenatal care visits: intervention [ Time Frame: 41 weeks gestation ]

    Number of prenatal care visits in which an intervention for blood sugars was recommended (e.g. starting medication or changing medication dose)

  • Symptomatic hypoglycemia [ Time Frame: 41 weeks gestation ]

    Frequency of symptomatic hypoglycemia episodes (hypoglycemia defined as <70 mg/dL per ADA)

  • Asymptomatic hypoglycemia [ Time Frame: 41 weeks gestation ]

    Frequency of asymptomatic hypoglycemia episodes (hypoglycemia defined as <70 mg/dL per ADA)

  • A1c enrollment [ Time Frame: At time of enrollment (up to 34 weeks gestation) ]

    Hemoglobin A1c at the time of enrollment

  • A1c 36 weeks [ Time Frame: At 36 weeks gestational age ]

    Hemoglobin A1c at 36 weeks gestational age

  • Lowest recorded blood sugar [ Time Frame: 41 weeks gestation ]

    Lowest recorded blood sugar during prenatal care

  • Highest recorded blood sugar [ Time Frame: 41 weeks gestation ]

    Highest recorded blood sugar during prenatal care

  • Average recorded blood sugar [ Time Frame: 41 weeks gestation ]

    Average recorded blood sugar during prenatal care

  • Weekly compliance [ Time Frame: 41 weeks gestation ]

    Average number of blood sugar checks actually performed each week

  • Weekly target assessment [ Time Frame: 41 weeks gestation ]

    % of blood sugars within goal each week

  • Diabetes medication [ Time Frame: 41 weeks gestation ]

    Did the patient need diabetes medication (including oral agents and insulin) during antepartum period?

  • Intrapartum insulin [ Time Frame: From onset of induction/labor until delivery ]

    Did the patient need insulin during the intrapartum period?

  • Gestational weight gain [ Time Frame: 41 weeks gestation ]

    Total weight gain during pregnancy in kilograms

  • Antepartum admission [ Time Frame: 41 weeks gestation ]

    Was the patient ever admitted to antepartum service for any indication, including poorly-controlled diabetes or diabetes-related complication?

  • Corticosteroids [ Time Frame: 41 weeks gestation ]

    Did the patient receive antenatal corticosteroid treatment?

  • Oligohydramnios [ Time Frame: 41 weeks gestation ]

    Amniotic fluid index <5 cm or maximum vertical pocket <2cm

  • Polyhydramnios [ Time Frame: 41 weeks gestation ]

    Amniotic fluid index >24cm or maximum vertical pocket >8cm

  • Fetal growth restriction [ Time Frame: 41 weeks gestation ]

    Ultrasonographic estimated fetal weight or abdominal circumference <10% for gestational ag

  • Gestational age at delivery [ Time Frame: During intrapartum admission to Labor & Delivery ]

    Gestational age at delivery

  • Induction of labor [ Time Frame: During intrapartum admission to Labor & Delivery ]

    Did the patient undergo induction of labor?

  • Mode of delivery [ Time Frame: During intrapartum admission to Labor & Delivery ]

    primary cesarean section, repeat cesarean section, vaginal delivery, vaginal delivery with vacuum, vaginal delivery with forceps

  • Cesarean indication [ Time Frame: During intrapartum admission to Labor & Delivery ]

    If the patient had cesarean delivery, what was the indication?

  • TOLAC [ Time Frame: During intrapartum admission to Labor & Delivery ]

    Did the patient attempt a trial of labor after cesarean?

  • Blood loss [ Time Frame: During intrapartum admission to Labor & Delivery ]

    Quantitative blood loss (or estimated if quantitative is unknown) in cc’s

  • 3rd or 4th degree laceration [ Time Frame: During intrapartum admission to Labor & Delivery ]

    3rd or 4th degree perineal laceration

  • PIH [ Time Frame: From 20 weeks gestation until 30 days postpartum ]

    Pregnancy-induced hypertension (gestational hypertension, preeclampsia, HELLP syndrome)

  • Hypertensive emergency [ Time Frame: From conception until 30 days postpartum ]

    Did the patient have severe-range blood pressures require antihypertensive medication?

  • Chorioamnionitis [ Time Frame: During intrapartum admission to Labor & Delivery ]

    Chorioamnionitis

  • Endometritis [ Time Frame: Within 30 days postpartum ]

    Endometritis

  • VTE [ Time Frame: From conception until 30 days postpartum ]

    Venous thromboembolism: deep venous thrombosis or pulmonary embolism

  • Length of stay (maternal) [ Time Frame: From admission to Labor & Delivery until discharge from postpartum ]

    Length of hospital admission for labor, delivery, and postpartum

  • Postpartum readmission [ Time Frame: Within 30 days postpartum ]

    Did the patient get readmitted within 30 days of delivery?

  • Postpartum wound complication [ Time Frame: Within 30 days postpartum ]

    Cesarean wound infection of dehiscence, perineal laceration breakdown

  • Cardiac complications [ Time Frame: From conception until 30 days postpartum ]

    Did the patient develop any cardiac complications such as arrhythmias or cardiomyopathy?

  • Seizures [ Time Frame: From conception until 30 days postpartum ]

    Did any maternal seizures occur during the pregnancy or postpartum?

  • Macrosomia [ Time Frame: Within 24 hours of birth ]

    Birth weight >4000 grams

  • LGA [ Time Frame: Within 24 hours of birth ]

    Large for gestational age (birth weight ≥90% for gestational age)

  • SGA [ Time Frame: Within 24 hours of birth ]

    Small for gestational age (birth weight <10% for gestational age)

  • Shoulder dystocia [ Time Frame: During intrapartum admission to Labor & Delivery ]

    Shoulder dystocia

  • Apgar [ Time Frame: 5 minutes after birth ]

    5-minute Apgar score

  • Cord gas pH <7.0 [ Time Frame: Within 24 hours of birth ]

    Did the baby have a cord blood gas pH <7.0?

  • Base excess [ Time Frame: Within 24 hours of birth ]

    What was the base excess on the cord blood gas?

  • Neonatal blood glucose [ Time Frame: Within 24 hours of birth ]

    What was the neonatal serum blood glucose at birth?

  • RDS [ Time Frame: Within 30 days of delivery ]

    Neonatal respiratory distress syndrome

  • TTN [ Time Frame: Within 30 days of delivery ]

    Transient tachypnea of the newborn

  • Hyperbilirubinemia [ Time Frame: Within 30 days of delivery ]

    Neonatal hyperbilirubinemia (as defined in AAP 2004 Clinical Practice Guideline “Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation”)

  • Neonatal sepsis [ Time Frame: Within 30 days of delivery ]

    Neonatal sepsis

  • NICU [ Time Frame: Within 30 days of delivery ]

    NICU admission

  • Length of stay (neonatal) [ Time Frame: From birth until discharge (up to 1 year) ]

    How many days after birth did the neonate stay in the hospital?

  • Congenital anomaly [ Time Frame: Within 30 days of delivery ]

    Congenital anomaly

  • IUFD or stillbirth [ Time Frame: From conception until delivery ]

    Intrauterine fetal demise or stillbirth

  • Source: View full study details on ClinicalTrials.gov

    The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

    October 21, 2022Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
    Comments